TaqIB polymorphism in the cholesteryl ester transfer protein (CETP) gene influences lipid responses to the consumption of kiwifruit in hypercholesterolaemic men

British Journal of Nutrition

Volumn 111, Issue 6, 2014, Pages 1077-1084

  Gammon, Cheryl S ^a   Minihane, Anne M ^b   Kruger, Rozanne ^a   Conlon, Cathryn A ^a   Von Hurst, Pamela R ^a   Jones, Beatrix ^c   Stonehouse, Welma ^a  

^a MASSEY UNIVERSITY   (New Zealand)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c MASSEY UNIVERSITY   (New Zealand)

Author keywords

CETP gene polymorphism; CVD risk; Diet gene interactions; Kiwifruit

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ASCORBIC ACID; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; CETP PROTEIN, HUMAN; HEPATIC LIPASE, HUMAN; LIPG PROTEIN, HUMAN; LIPID; TRIACYLGLYCEROL LIPASE;

ACTINIDIA DELICIOSA; ADULT; APOA1 GENE; ARTICLE; BODY FAT; BODY MASS; CALORIC INTAKE; CETP GENE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET THERAPY; FOOD INTAKE; GENE; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; LIPC GENE; LIPG GENE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; THERAPY EFFECT; TREATMENT DURATION; WEIGHT REDUCTION; ACTINIDIA; BLOOD; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DIET; FRUIT; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ACTINIDIA DELICIOSA;

ACTINIDIA; ADULT; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CROSS-OVER STUDIES; DIET; FRUIT; GENOTYPE; HUMANS; HYPERCHOLESTEROLEMIA; LIPASE; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES;

EID: 84899683058     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513003437     Document Type: Article

References (39)

1. WHO (2011) Cardiovascular Diseases Fact Sheet no. 317. Geneva: World Health Organization.
2. Vergeer M, Holleboom AG, Kastelein JJP, et al. (2010) The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? J Lipid Res 51, 2058-2073.
3. Hansel B, Kontush A, Giral P, et al. (2006) One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: The Paris La Pitie Study. Curr Med Res Opin 22, 1149-1160.
4. Musunuru K (2010) Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids 45, 907-914.
5. Bove M, Cicero AFG, Manca M, et al. (2007) Sources of variability of plasma HDL-cholesterol levels. Future Lipidol 2, 557-569.
6. Heller DA, de Faire U, Pedersen NL, et al. (1993) Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 328, 1150-1156.
7. Peloso GM, Demissie S, Collins D, et al. (2010) Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease. J Lipid Res 51, 3524-3532.
8. Chong MF, Macdonald R & Lovegrove JA (2010) Fruit polyphenols and CVD risk: a review of human intervention studies. Br J Nutr 104, Suppl. 3, S28-S39.
9. Dauchet L, Amouyel P, Dallongeville J, et al. (2009) Fruits, vegetables and coronary heart disease. Nat Rev Cardiol 6, 599-608.
10. Gammon CS, Kruger R, Minihane AM, et al. (2013) Kiwifruit consumption favourably affects plasma lipids in a randomised controlled trial in hypercholesterolaemic men. Br J Nutr 109, 2208-2218.
11. de Grooth GJ, Klerkx AH, Stroes ES, et al. (2004) A review of CETP and its relation to atherosclerosis. J Lipid Res 45, 1967-1974.
12. Boekholdt SM, Sacks FM, Jukema JW, et al. (2005) Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient metaanalysis of 13,677 subjects. Circulation 111, 278-287.
13. Thompson A, Di Angelantonio E, Sarwar N., et al. (2008) Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA 299, 2777-2788.
14. Mank-Seymour AR, Durham KL, Thompson JF, et al. (2004) Association between single-nucleotide polymorphisms in the endothelial lipase (LIPG) gene and high-density lipoprotein cholesterol levels. Biochim Biophys Acta 1636, 40-46.
15. Nettleton JA, Steffen LM, Ballantyne CM, et al. (2007) Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults. Atherosclerosis 194, e131-e140.
16. Ordovas JM, Corella D, Demissie S, et al. (2002) Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 106, 2315-2321.
17. Zhang C, Lopez-Ridaura R, Rimm EB, et al. (2005) Interactions between the 2 514C- > T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men. Am J Clin Nutr 81, 1429-1435.
18. Juo SH, Wyszynski DF, Beaty TH, et al. (1999) Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-I levels: a meta-analysis. Am J Med Genet 82, 235-241.
19. Ruano G, Seip RL, Windemuth A, et al. (2006) Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training. Atherosclerosis 185, 65-69.
20. Souverein OW, Jukema JW, Boekholdt SM, et al. (2005) Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD. Eur J Hum Genet 13, 445-451.
21. Wallace TM, Levy JC & Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27, 1487-1495.
22. Stampfer MJ, Sacks FM, Salvini S, et al. (1991) A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 325, 373-381.
23. Do HQ, Nazih H, Luc G, et al. (2009) Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study. Metabolism 58, 283-289.
24. Smith CE, Arnett DK, Tsai MY, et al. (2009) Physical inactivity interacts with an endothelial lipase polymorphism to modulate high density lipoprotein cholesterol in the GOLDN study. Atherosclerosis 206, 500-504.
25. Ordovas JM, Corella D, Cupples LA, et al. (2002) Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr 75, 38-46.
26. Barter PJ, Brewer HB Jr, Chapman MJ, et al. (2003) Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 23, 160-167.
27. Chapman MJ, Le Goff W, Guerin M, et al. (2010) Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Eur Heart J 31, 149-164.
28. Charles MA & Kane JP (2012) New molecular insights into CETP structure and function: a review. J Lipid Res 53, 1451-1458.
29. Boekholdt SM & Thompson JF (2003) Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease. J Lipid Res 44, 1080-1093.
30. Dullaart RPF & Sluiter WJ (2008) Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis. Pharmacogenomics 9, 747-763.
31. Millan J, Pinto X, Munoz A, et al. (2009) Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag 5, 757-765.
32. Cordero A, Andres E, Ordonez B, et al. (2009) Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men. Am J Cardiol 104, 1393-1397.
33. Miller M, Stone NJ, Ballantyne C, et al. (2011) Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123, 2292-2333.
34. Lam CK, Zhang Z, Yu H, et al. (2008) Apple polyphenols inhibit plasma CETP activity and reduce the ratio of non-HDL to HDL cholesterol. Mol Nutr Food Res 52, 950-958.
35. Fiorentino A, D'Abrosca B, Pacifico S, et al. (2009) Identification and assessment of antioxidant capacity of phytochemicals from kiwi fruits. J Agric Food Chem 57, 4148-4155.
36. Latocha P, Krupa T, Wolosiak R, et al. (2010) Antioxidant activity and chemical difference in fruit of different Actinidia sp. Int J Food Sci Nutr 61, 381-394.
37. Tarascou I, Souquet JM, Mazauric JP, et al. (2010) The hidden face of food phenolic composition. Arch Biochem Biophys 501, 16-22.
38. Rideout TC (2011) Getting personal: considering variable interindividual responsiveness to dietary lipid-lowering therapies. Curr Opin Lipidol 22, 37-42.
39. Minihane AM (2013) The genetic contribution to disease risk and variability in response to diet: where is the hidden heritability? Proc Nutr Soc 72, 40-47.